300003 乐普医疗
已收盘 08-18 15:00:00
资讯
新帖
简况
乐普医疗最新公告：子公司MWN117注射液获临床试验批准
证券之星 · 08-17 19:09
乐普医疗最新公告：子公司MWN117注射液获临床试验批准
乐普医疗（300003）披露持股5%以上股东拟发行科技创新可交换债获深交所无异议函，8月13日股价上涨1.23%
证券之星 · 08-13
乐普医疗（300003）披露持股5%以上股东拟发行科技创新可交换债获深交所无异议函，8月13日股价上涨1.23%
乐普医疗最新公告：子公司MWN110注射液获临床试验批准
证券之星 · 07-15
乐普医疗最新公告：子公司MWN110注射液获临床试验批准
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月13日股价下跌1.71%
证券之星 · 07-13
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月13日股价下跌1.71%
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月6日股价上涨2.15%
证券之星 · 07-06
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月6日股价上涨2.15%
乐普医疗（300003）股东蒲忠杰质押2793万股，占总股本1.52%
证券之星 · 07-06
乐普医疗（300003）股东蒲忠杰质押2793万股，占总股本1.52%
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月2日股价上涨0.16%
证券之星 · 07-02
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月2日股价上涨0.16%
乐普医疗（300003）股东蒲忠杰质押1193万股，占总股本0.65%
证券之星 · 07-02
乐普医疗（300003）股东蒲忠杰质押1193万股，占总股本0.65%
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，6月30日股价下跌2.39%
证券之星 · 06-30
乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，6月30日股价下跌2.39%
股市必读：6月26日乐普医疗现3600万元大宗交易
证券之星 · 06-29
股市必读：6月26日乐普医疗现3600万元大宗交易
信诺维科创板IPO过会：年营收9亿，净利2亿 拟募资29亿 腾讯是股东
雷递网 · 06-26
信诺维科创板IPO过会：年营收9亿，净利2亿 拟募资29亿 腾讯是股东
每周股票复盘：乐普医疗（300003）完成5亿元科创债发行
证券之星 · 06-21
每周股票复盘：乐普医疗（300003）完成5亿元科创债发行
乐普医疗（300003）披露2025年年度权益分派实施公告，6月18日股价上涨1.03%
证券之星 · 06-18
乐普医疗（300003）披露2025年年度权益分派实施公告，6月18日股价上涨1.03%
乐普医疗最新公告：子公司双靶点siRNA药物MWX205注射液获澳洲临床试验批准
证券之星 · 06-08
乐普医疗最新公告：子公司双靶点siRNA药物MWX205注射液获澳洲临床试验批准
乐普医疗（300003）2026年一季报简析：净利润同比下降34.8%，公司应收账款体量较大
证券之星 · 04-24
乐普医疗（300003）2026年一季报简析：净利润同比下降34.8%，公司应收账款体量较大
【机构调研记录】国泰海通证券调研乐普医疗、甘源食品等7只个股（附名单）
证券之星 · 04-24
【机构调研记录】国泰海通证券调研乐普医疗、甘源食品等7只个股（附名单）
【机构调研记录】中银基金调研乐普医疗、水晶光电
证券之星 · 04-24
【机构调研记录】中银基金调研乐普医疗、水晶光电
乐普医疗：公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况
证券之星 · 04-23
乐普医疗：公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况
图解乐普医疗一季报：第一季度单季净利润同比下降34.80%
证券之星 · 04-23
图解乐普医疗一季报：第一季度单季净利润同比下降34.80%
乐普医疗最新公告：子公司拟4.5亿元受让贝塔宁®品种权益
证券之星 · 04-14
乐普医疗最新公告：子公司拟4.5亿元受让贝塔宁®品种权益
加载更多
公司概况
公司名称：
乐普(北京)医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2009-10-30
主营业务：
乐普(北京)医疗器械股份有限公司的主营业务是医疗器械及其配件的技术开发、生产，销售。公司的主要产品是医疗器械、药品、医疗服务、健康管理。公司拥有国家科技部授予的“国家心脏病植介入诊疗器械及装备工程技术研究中心”称号。
发行价格：
29.00
{"stockData":{"symbol":"300003","market":"SZ","secType":"STK","nameCN":"乐普医疗","latestPrice":12.58,"timestamp":1787036592000,"preClose":12.72,"halted":0,"volume":25090342,"delay":0,"changeRate":-0.011,"floatShares":1579000000,"shares":1843000000,"eps":0.4505,"marketStatus":"已收盘","change":-0.14,"latestTime":"08-18 15:00:00","open":12.76,"high":12.86,"low":12.52,"amount":317000000,"amplitude":0.0267,"askPrice":12.59,"askSize":193,"bidPrice":12.58,"bidSize":780,"shortable":0,"etf":0,"ttmEps":0.4505,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787103000000},"marketStatusCode":5,"adr":0,"adjPreClose":12.72,"symbolType":"stock","openAndCloseTimeList":[[1787016600000,1787023800000],[1787029200000,1787036400000]],"highLimit":13.99,"lowLimit":11.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1843424716,"isCdr":false,"pbRate":1.43,"roa":"--","peRate":27.924528,"roe":"1.52%","epsLYR":0.5219,"committee":0.424638,"marketValue":23190000000,"turnoverRate":0.0159,"status":1,"floatMarketCap":19863000000},"requestUrl":"/m/hq/s/300003/","defaultTab":"news","newsList":[{"id":"2660484463","title":"乐普医疗最新公告：子公司MWN117注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484463","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660484463?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:09","pubTimestamp":1786964968,"startTime":"0","endTime":"0","summary":"乐普医疗(300003.SZ)公告称，公司控股子公司上海民为生物收到国家药监局核准签发的《药物临床试验批准通知书》，MWN117注射液临床试验申请获批准，适应症为超重或肥胖。该药物为自主研发的靶向抑制INHBE的siRNA药物，拥有全球知识产权，目前国内外尚无同类药物获批上市。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700028169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003","BK0251","BK0113","BK0028","BK0196","BK0114","BK0042","BK0188","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168461","title":"乐普医疗（300003）披露持股5%以上股东拟发行科技创新可交换债获深交所无异议函，8月13日股价上涨1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659168461?lang=zh_cn&edition=full","pubTime":"2026-08-13 22:14","pubTimestamp":1786630460,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，乐普医疗报收于13.16元，较前一交易日上涨1.23%，最新总市值为242.59亿元。该股当日开盘12.92元，最高13.38元，最低12.77元，成交额达6.96亿元，换手率为3.35%。乐普医疗当日发布《关于持股5%以上股东拟非公开发行科技创新可交换公司债券获得深圳证券交易所无异议函的提示性公告》。截至公告日，七二五所持有公司244,063,788股，占总股本13.24%。公司将按规定履行后续信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300039587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300003","BK0114","BK0251","BK0196","BK0113","BK0201","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651454029","title":"乐普医疗最新公告：子公司MWN110注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2651454029","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651454029?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:31","pubTimestamp":1784111505,"startTime":"0","endTime":"0","summary":"乐普医疗(300003.SZ)公告称，公司控股子公司上海民为生物技术有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，其申报的MWN110注射液临床试验申请获批，适应症为成人体重控制。该药物为靶向ActRIIA/B的单克隆抗体，非临床研究显示其可显著降低体脂率、体重并增加肌肉量，与司美格鲁肽联用可抑制肌肉流失，且安全性良好。目前国内外尚无同类药物上市，但后续临床试验存在不确定性风险。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500037608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0251","BK0028","BK0188","BK0196","BK0201","BK0113","300003","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651819078","title":"乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月13日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651819078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651819078?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:46","pubTimestamp":1783936007,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，乐普医疗报收于12.09元，较前一交易日下跌1.71%，最新总市值为222.87亿元。乐普医疗近日披露《关于控股股东部分股权质押及解除质押的公告》。本次解除质押32,000,000股，占其所持股份比例7.02%，占公司总股本1.74%；同时新质押40,750,000股，占其所持股份比例8.94%，占公司总股本2.21%，质押用途为偿还债务，质权人均为中国银河证券股份有限公司。截至公告日，蒲忠杰及其一致行动人累计质押股份190,419,996股，占其持股总数的41.79%，占公司总股本10.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300003","BK0251","BK0188","BK0201","BK0114","BK0113","BK0042","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649627402","title":"乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月6日股价上涨2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649627402","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649627402?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:28","pubTimestamp":1783348099,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，乐普医疗报收于12.83元，较前一交易日上涨2.15%，最新总市值为236.51亿元。乐普医疗于近日披露《关于控股股东部分股权质押及解除质押的公告》。公告显示，公司控股股东蒲忠杰先生近期办理了部分股权的质押及解除质押：解除质押股份合计11,930,000股，占公司总股本0.65%；同时新质押27,930,000股，占公司总股本1.52%，质押用途为偿还债务。截至公告日，蒲忠杰及其一致行动人累计质押股份181,669,996股，占其持股总数的39.87%，占公司总股本9.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0201","BK0196","BK0188","BK0113","300003","BK0251","BK0114","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649623226","title":"乐普医疗（300003）股东蒲忠杰质押2793万股，占总股本1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649623226","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649623226?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:31","pubTimestamp":1783333861,"startTime":"0","endTime":"0","summary":"证券之星消息，乐普医疗7月6日公开信息显示，股东蒲忠杰向国泰海通证券股份有限公司合计质押2793.0万股，占总股本1.52%。质押详情见下表：截止本公告日，股东蒲忠杰已累计质押股份1.26亿股，占其持股总数的55.1%，股东北京厚德义民投资管理有限公司已累计质押股份2683.0万股，占其持股总数的39.6%。乐普医疗主营业务：提供心血管疾病领域全生命周期的整体解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600029579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0042","BK0114","BK0028","300003","BK0201","BK0188","BK0251","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648868658","title":"乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，7月2日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648868658","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648868658?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:41","pubTimestamp":1783003277,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，乐普医疗报收于12.5元，较前一交易日上涨0.16%，最新总市值为230.43亿元。近日，乐普医疗披露《关于控股股东部分股权质押及解除质押的公告》。本次解除质押股份合计27,929,998股，占公司总股本的1.52%；同时新增质押11,930,000股，占公司总股本的0.65%，用于偿还债务。质押股份未触及平仓线，不存在平仓风险。截至公告日，蒲忠杰及其一致行动人累计质押股份165,669,996股，占其持股总数的36.36%，占公司总股本的8.99%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0251","BK0113","BK0114","300003","BK0028","BK0196","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648018435","title":"乐普医疗（300003）股东蒲忠杰质押1193万股，占总股本0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648018435","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648018435?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:29","pubTimestamp":1782988165,"startTime":"0","endTime":"0","summary":"证券之星消息，乐普医疗7月2日公开信息显示，股东蒲忠杰向国泰海通证券股份有限公司合计质押1193.0万股，占总股本0.65%。质押详情见下表：截止本公告日，股东蒲忠杰已累计质押股份1.1亿股，占其持股总数的48.09%，股东北京厚德义民投资管理有限公司已累计质押股份2683.0万股，占其持股总数的39.6%。乐普医疗主营业务：提供心血管疾病领域全生命周期的整体解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200034377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0114","300003","BK0201","BK0028","BK0042","BK0113","BK0188","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537132","title":"乐普医疗（300003）披露控股股东部分股权质押及解除质押公告，6月30日股价下跌2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537132","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647537132?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:29","pubTimestamp":1782815350,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，乐普医疗报收于11.85元，较前一交易日下跌2.39%，最新总市值为218.45亿元。近日，乐普医疗发布《关于控股股东部分股权质押及解除质押的公告》。本次解除质押38,120,000股，占其所持股份的8.37%，占公司总股本的2.07%；同时新增质押39,630,000股，占其所持股份的8.70%，占公司总股本的2.15%，质押用途为偿还债务。截至公告日，蒲忠杰及其一致行动人合计持有公司股份455,643,349股，占公司总股本的24.72%，累计质押股份181,669,994股，占公司总股本的9.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000036719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0114","300003","BK0201","BK0028","BK0042","BK0113","BK0188","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647348290","title":"股市必读：6月26日乐普医疗现3600万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2647348290","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647348290?lang=zh_cn&edition=full","pubTime":"2026-06-29 02:09","pubTimestamp":1782670151,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，乐普医疗报收于11.37元，下跌4.05%，换手率1.68%，成交量26.6万手，成交额3.09亿元。当日关注点交易信息汇总：6月26日乐普医疗主力资金净流出2669.58万元。大宗交易6月26日乐普医疗发生3600万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0042","BK0114","BK0113","300003","BK0251","BK0196","BK0028","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646500323","title":"信诺维科创板IPO过会：年营收9亿，净利2亿 拟募资29亿 腾讯是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2646500323","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646500323?lang=zh_cn&edition=full","pubTime":"2026-06-26 21:29","pubTimestamp":1782480564,"startTime":"0","endTime":"0","summary":"苏州信诺维医药科技股份有限公司（简称：“信诺维”）日前IPO过会，准备在科创板上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260626/6391810613514447845039244.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260626/6391810613514447845039244.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34169/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["LU0516422952.EUR","IE0032834883.USD","LU0516422366.SGD","LU1023057109.AUD","LU2317271919.USD","LU0648948544.HKD","LU0572940350.SGD","LU1733274390.USD","LU0873338254.USD","SG9999013353.USD","LU0211331839.USD","LU1568876335.HKD","LU0143863784.USD","LU2097828557.USD","LU1810669033.SGD","LU0048597586.USD","LU0882747503.HKD","BK1609","LU0708995153.HKD","LU0067412154.USD","LU2399975544.HKD","SG9999001226.SGD","BK1526","IE0008368742.USD","SG9999014914.USD","LU1044874839.SGD","LU2476274308.USD","LU0823039010.USD","LU0315178854.USD","LU1224709979.USD","LU1328277881.USD","LU0431992006.USD","SG9999006597.SGD","LU0329678170.USD","LU0320764599.SGD","LU0370786039.SGD","LU1226287875.USD","LU0143863198.USD","LU1282649810.SGD","LU1439103000.SGD","LU1981816686.USD","BK1589","LU1814569148.SGD","LU1242518931.SGD","LU0307460666.USD","SG9999015978.USD","LU1808992512.USD","LU1303224171.USD","IE00B5MMRT66.SGD","LU1196710195.USD","LU0577902611.USD","SG9999001689.USD","LU0456846285.SGD","LU1956131251.USD","LU0181495838.USD","LU0070217475.USD","SG9999015952.SGD","IE00BF5LJ272.USD","LU0054237671.USD","IE0008368411.USD","LU1226288097.SGD","LU0828237940.HKD","LU0823038988.USD","IE00BQXX3D17.EUR","LU0261947096.USD","LU0608807433.USD","LU0588545904.SGD","LU1794554557.SGD","LU1813983027.USD","LU0106259558.USD","LU0175139822.USD","LU2097828714.EUR","LU2097828805.USD","LU0516422440.USD","LU2237443622.USD","LU2362541273.HKD","LU1316542783.SGD","LU0865486749.SGD","LU0188438112.USD","SGXZ99366536.SGD","LU1917777945.USD","SG9999001846.SGD","LU0348805143.USD","LU2125910500.SGD","LU0823413587.USD","IE00B8HQ1Z84.USD","LU0577902454.USD","LU1251922891.USD","LU0072913022.USD","BK0251","LU0516423174.USD","LU0164872284.USD","LU0589944569.HKD","LU0049853897.USD","SGXZ31699556.SGD","LU0417516738.SGD","SG9999002562.SGD","SG9999002463.SGD","LU0192582467.USD","LU0061477393.USD","LU0878005551.USD","LU2498475776.HKD","IE00BZ08YS42.EUR","LU0985320562.USD","HK0001040168.HKD","LU2097828631.EUR","SG9999004220.SGD","LU0642271901.SGD","LU1224444064.USD","LU2476274720.SGD","LU1102505929.USD","LU1048588211.SGD","LU0823397103.USD","LU1720050803.USD","LU2237443382.USD","TCHmain","LU0786609619.USD","LU0328353924.USD","HK0000914686.HKD","LU2045819591.USD","LU1951186391.HKD","LU0499858602.USD","HK0000320223.HKD","LU1769817179.HKD","LU0651947912.USD","IE00B29SXG58.USD","LU0463099449.HKD","LU0210533765.USD","LU1115378108.SGD","LU0047713382.USD","LU0106252389.USD","LU0231483743.USD","LU0326950275.SGD","LU0823397285.USD","LU1048484197.HKD","LU0043850808.USD","SG9999003461.SGD","LU0456827905.SGD","LU1733274473.HKD","LU1769817096.USD","LU0072462343.USD","LU0132412106.USD","LU0261950983.USD","LU2251237488.HKD","BK0042","IE00B031J352.USD","LU1675838814.USD","LU0052750758.USD","GB00BDT5M118.USD","LU1328615791.USD","LU0541502299.USD","IE00B0JY6N72.USD","LU1282651048.USD","HK0000320264.USD","HTCD.SI","LU1688375341.USD","LU0348814723.USD","LU1152091754.HKD","LU3063872942.SGD","LU0880133367.SGD","LU0048388663.USD","LU0608807946.USD","LU1960683339.HKD","LU0594300179.USD","LU0633140560.USD","LU0871576103.HKD","LU0049112450.USD","LU0541501648.USD","LU0348783662.USD","LU1152091168.USD","LU1282649067.USD","LU0011963245.USD","LU0254981946.USD","LU0348788117.USD","LU0823426480.USD","LU1366334651.USD","LU1725190679.HKD","LU0819121731.USD","LU0856984785.SGD","LU1051769294.HKD","SG9999014898.SGD","LU0107464264.USD","LU0821914370.USD","BK1095","LU0797268264.HKD","LU0890818403.SGD","LU0831103253.SGD","BK1586","LU1807302812.USD","HK0000151867.HKD","LU0359202008.SGD","LU0128522744.USD","LU1064130708.USD","LU0348825331.USD","LU1046422090.SGD","LU0918141705.HKD","BK0188","LU0029874905.USD","LU0054450605.USD","BK1531","LU0588545730.USD","LU0235996351.USD","LU1196710351.USD","LU1105468828.SGD","LU0502904849.HKD","IE00B067MR52.USD","LU1974910355.USD","LU0210526637.USD","LU0588546209.SGD","LU0819123356.HKD","LU0203345920.USD","LU2265009873.SGD","LU0651946864.USD","IE00B97KM107.HKD","LU0572944931.SGD","LU2106854487.HKD","LU2293587155.HKD","LU0594300419.USD","LU0737861699.HKD","LU0862451753.SGD","IE0031814852.USD","SGXZ51526630.SGD","SG9999017495.SGD","BK1521","LU0210527791.USD","LU0051755006.USD","LU1831875114.USD","LU2257852520.SGD","BK0196","LU0039217434.USD","LU0315179316.USD","LU1226288170.HKD","LU0543330566.HKD","HK0000306701.USD","LU0577902371.SGD","LU0650527681.SGD","SG9999000459.SGD","LU2247934214.USD","IE00B543WZ88.USD","LU0823426308.USD","LU0259732245.USD","LU0348816934.USD","LU0738912210.USD","BK0113","LU1323998911.USD","LU1655091459.SGD","LU1961090484.USD","SGXZ90724238.SGD","LU1051768304.USD","LU2242644610.SGD","IE0001KFT4U8.USD","LU0128522157.USD","LU0823041008.USD","LU0593848301.USD","LU1504937902.USD","LU0700851271.USD","LU0823413660.USD","LU1770036033.HKD","BK1618","LU1102505762.USD","IE00B3M56506.USD","IE00B031HW06.USD","LU1868837565.USD","LU0348784397.USD","LU0127658192.USD","LU0214875030.USD","LU1282649141.HKD","LU0229945570.USD","LU0345775950.USD","LU1481107354.HKD","LU1044876610.USD","LU0359201885.HKD","LU2237443895.HKD","SG9999001069.SGD","LU0791590937.USD","HK0001040143.USD","SG9999015986.USD","SG9999014906.USD","LU0543330483.HKD","LU0293314216.USD","LU0314109678.HKD","LU0640798160.USD","LU0080751232.USD","LU1770034418.SGD","LU0345776255.USD","LU1188198961.HKD","LU0163747925.USD","LU0164865239.USD","LU0164880469.USD","LU0509642566.USD","LU2039709279.SGD","IE0003895053.USD","LU2008162690.USD","LU0203347892.USD","LU1785774172.SGD","LU2023250504.SGD","LU0211977185.USD","LU1366334578.USD","IE00B0169N27.USD","LU0244354667.USD","LU0449515922.USD","SG9999007991.SGD","LU1993786604.SGD","LU0169518387.USD","LU1242518857.USD","LU1226288253.USD","LU0577902298.EUR","LU0862451837.USD","LU0149721374.USD","LU1064131003.USD","LU0455707207.USD","LU0348723411.USD","HK0000914660.USD","LU0149534421.HKD","SG9999014674.SGD","LU0117841782.USD","LU1282648689.USD","LU0329678337.USD","LU1868838027.USD","LU0417516902.SGD","LU2279701549.SGD","LU0737861772.HKD","LU0501845795.SGD","SG9999018865.SGD","SG9999018857.SGD","LU0516423091.SGD","LU0106959298.USD","LU3227948356.SGD","LU0607220059.USD","LU0287142896.SGD","300003","LU0886674414.USD","BK1591","LU0096374516.USD","SG9999001903.USD","BK1615","LU0791591158.USD","LU0488056044.USD","LU0918141887.USD","LU0605514214.HKD","IE0009570106.USD","IE0008369823.USD","IE00BPRC5H50.USD","SG9999002828.SGD","LU1048596156.SGD","IE00B8L5B284.USD","LU2778985437.USD","LU2237443978.SGD","IE0003795394.USD","BK1610","LU1691799644.USD","LU0384037296.USD","LU1235295612.USD","LU2097828474.EUR","LU2148510915.USD","SG9999001051.SGD","SGXZ81514606.USD","IE00BZ08YR35.GBP","IE0032431581.USD","SG9999006514.SGD","SG9999015945.SGD","LU0672654166.SGD","IE00B031HY20.USD","LU2177674079.SGD","LU1008478684.HKD","LU0345769631.USD","LU0633140727.USD","IE0034224299.USD","LU2237443465.HKD","LU0048580855.USD","BK1502","LU0228659784.USD","LU2051468812.USD","IE00BGV7N243.SGD","LU0449509016.USD","IE00BQXX3C00.GBP","LU2362540622.SGD","LU0414403682.SGD","LU1196710864.SGD","LU2294711473.HKD","LU0540923850.HKD","LU0173614495.USD","LU0417516571.SGD","LU0320764243.SGD","LU2152927971.USD","LU0898667661.SGD","LU2449936058.SGD","LU2237443549.SGD","LU0634319403.HKD","LU2125910849.SGD","LU0084288322.USD","LU1568876251.USD","LU0708995583.HKD","BK1608","IE00BQXX3F31.USD","IE00BZ08YT58.USD","IE00B0169L03.USD","LU0326948709.USD","LU0269904917.USD","LU0359201612.USD","LU0140636845.USD","BK1517","LU0784639295.USD","BK0028","LU1226287792.SGD","LU1804176565.USD","LU0868486357.SGD","LU0683595622.HKD","LU1734074674.USD","LU0878004406.USD","LU1226287529.USD","LU1439102457.SGD","LU0456842615.SGD","LU0327786744.USD","LU0828237510.HKD","LU0289960550.SGD","LU0345769128.USD","LU0979878070.USD","LU0499858438.USD","LU0823040885.USD","TCEHY","LU2226246903.HKD","LU0251144936.SGD","LU1642822792.SGD","LU1282651121.HKD","LU0029875118.USD","BK0201","SG9999000418.SGD","00700","LU0531970944.HKD","SG9999014880.SGD","LU0572939691.SGD","IE0003851619.USD","LU2087589342.USD","LU0469268626.HKD","LU0972618739.USD","LU0320764755.SGD","LU1719994722.HKD","LU0577902538.SGD","LU0117844026.USD","LU1044875133.USD","LU1880383440.USD","LU0228367735.SGD","LU1718418525.SGD","LU0675040207.SGD","LU0561508036.HKD","LU0396098781.USD","LU0588545490.SGD","LU2362541513.USD","LU0828238088.HKD","LU0165289439.USD","LU2251237306.USD","BK1516","LU2133065610.SGD","LU1211504680.USD","HK0000352291.HKD","LU0441854154.USD","HK0000306685.HKD","LU2462611646.USD","SG9999001093.SGD","LU1515016050.SGD","BK0114","LU0348783233.USD","LU0531971595.HKD","LU0348735423.USD","LU0348827113.USD","LU1629966141.USD","SG9999000327.SGD","LU0611395673.USD","HK0000352382.USD","LU0196878994.USD","LU1880383366.USD","LU1883866441.USD","LU1868837722.USD","LU0264606111.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645968240","title":"每周股票复盘：乐普医疗（300003）完成5亿元科创债发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2645968240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645968240?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:43","pubTimestamp":1781980990,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，乐普医疗报收于11.82元，较上周的11.75元上涨0.6%。本周，乐普医疗6月15日盘中最高价报12.1元。本周关注点公司公告汇总：乐普医疗完成2026年度第一期科技创新债券发行，总额5亿元，利率2.20%。公司公告汇总：乐普医疗2025年年度权益分派实施，每10股派发现金红利1.6275元（含税）。乐普（北京）医疗器械股份有限公司2025年年度利润分配方案已获2026年5月13日召开的年度股东会审议通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","159115","BK0196","BK0042","BK0028","300003","BK0114","BK0188","BK0251","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644701294","title":"乐普医疗（300003）披露2025年年度权益分派实施公告，6月18日股价上涨1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644701294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644701294?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:36","pubTimestamp":1781775367,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，乐普医疗报收于11.82元，较前一交易日上涨1.03%，最新总市值为217.89亿元。乐普（北京）医疗器械股份有限公司于近日披露《2025年年度权益分派实施公告》。公告显示，公司2025年年度利润分配方案已获2026年5月13日召开的年度股东会审议通过。本次权益分派股权登记日为2026年6月25日，除权除息日为2026年6月26日。自方案披露至实施期间，公司股本总额未发生变动，实施的方案与股东会审议通过的一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0201","BK0113","300003","BK0196","BK0251","BK0188","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641862824","title":"乐普医疗最新公告：子公司双靶点siRNA药物MWX205注射液获澳洲临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2641862824","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641862824?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:01","pubTimestamp":1780916487,"startTime":"0","endTime":"0","summary":"乐普医疗(300003.SZ)公告称，公司控股子公司上海民为生物自主研发的双靶点siRNA药物MWX205注射液，已向澳大利亚人类研究伦理委员会提交I期临床试验申请并获得批准。该药物为全球首个进入临床阶段的PCSK9和ANGPTL3双靶点siRNA药物，非临床研究显示在恒河猴中可显著降低LDL-C、TG和TC，最大下降率分别为74.28%、82.30%和52.13%，且具有良好的安全性。公司提示，该药物尚处研发早期，存在临床试验失败和审批风险。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800028383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0188","BK0201","BK0196","BK0251","300003","BK0028","BK0113","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629840037","title":"乐普医疗（300003）2026年一季报简析：净利润同比下降34.8%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2629840037","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629840037?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:34","pubTimestamp":1777041290,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期乐普医疗发布2026年一季报。截至本报告期末，公司营业总收入16.72亿元，同比下降3.7%，归母净利润2.47亿元，同比下降34.8%。本报告期乐普医疗公司应收账款体量较大，当期应收账款占最新年报归母净利润比达232.94%。然而去年的净利率为15.72%，算上全部成本后，公司产品或服务的附加值高。持有乐普医疗最多的基金为医疗器械ETF永赢，目前规模为55.46亿元，最新净值0.4849，较上一交易日下跌0.66%，近一年上涨4.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629862487","title":"【机构调研记录】国泰海通证券调研乐普医疗、甘源食品等7只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2629862487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629862487?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:04","pubTimestamp":1776989056,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月23日披露的机构调研信息，国泰海通证券近期对7家上市公司进行了调研。部分品类均价上升系销售结构变化所致，非普遍提价。5）蓝晓科技 调研纪要：2025年公司金属资源领域收入3.16亿元，同比增长23%，在提镍、提钒、提镓等领域取得突破。与2025年第四季度相比，营业收入和净利润环比均有所增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400023459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02611","300003","BK0042","BK0238","BK0012","BK0184","BK0201","BK0251","BK0113","601211","BK0188","BK0183","002991","BK1147","BK0114","BK1564","161027","BK0276","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629625678","title":"【机构调研记录】中银基金调研乐普医疗、水晶光电","url":"https://stock-news.laohu8.com/highlight/detail?id=2629625678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629625678?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:02","pubTimestamp":1776988978,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月23日披露的机构调研信息，中银基金近期对2家上市公司进行了调研，相关名单如下：1）乐普医疗 个股亮点：乐普瑞康(北京)养老服务管理有限公司为公司的子公司，公司持有其70.18%股权，主要从事老人养老服务，护理服务。；水晶光电储能5MW/10MWh项目已投运。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400023373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0064","BK0072","BK0042","BK0109","BK0251","300003","BK0108","BK0214","BK0070","BK0198","002273","BK0196","BK0077","BK0201","BK0028","BK0114","BK0188","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629883429","title":"乐普医疗：公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2629883429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629883429?lang=zh_cn&edition=full","pubTime":"2026-04-23 15:45","pubTimestamp":1776930312,"startTime":"0","endTime":"0","summary":"证券之星消息，乐普医疗(300003)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司重磅创新药MWN109注射液二期低剂量组临床试验已经结束，临床数据何时公布？公司对该管线对外BD授权的预期和安排如何？乐普医疗回复：尊敬的投资者您好，目前该临床研究数据尚未揭盲，公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况，请您关注公司官方公告，感谢您对公司的关心。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300039606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0201","BK0113","300003","BK0196","BK0251","BK0188","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629202437","title":"图解乐普医疗一季报：第一季度单季净利润同比下降34.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629202437","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629202437?lang=zh_cn&edition=full","pubTime":"2026-04-23 02:29","pubTimestamp":1776882581,"startTime":"0","endTime":"0","summary":"证券之星消息，乐普医疗2026年一季报显示，一季度公司主营收入16.72亿元，同比下降3.7%；归母净利润2.47亿元，同比下降34.8%；扣非净利润2.41亿元，同比下降28.45%；负债率29.75%，投资收益73.9万元，财务费用1.38亿元，毛利率62.03%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300004466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464614","title":"乐普医疗最新公告：子公司拟4.5亿元受让贝塔宁®品种权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627464614?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:30","pubTimestamp":1776169829,"startTime":"0","endTime":"0","summary":"乐普医疗公告称，公司子公司乐普药业与百奥泰签署协议，以4.5亿元(含税)受让贝塔宁制剂及原料药品种权益及相关资产与业务。款项分五期支付，在完成MAH转移及生产转移获批后付清。此外，乐普药业还将按目标药品年度净销售额的个位数百分比获取销售分成，最长分成期为10年。该药品为化学药品1类创新药，主要用于PCI术后急性冠脉综合征患者。本次交易不构成关联交易及重大资产重组，无需提交董事会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400035618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003","BK0196","BK0188","BK0113","BK0201","BK0251","BK0028","BK0042","BK0114"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787086593258,"stockEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":0},{"period":"3month","weight":-0.0376},{"period":"6month","weight":-0.2828},{"period":"1year","weight":-0.3042},{"period":"ytd","weight":-0.1934}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0601},{"period":"3month","weight":-0.0413},{"period":"6month","weight":-0.0225},{"period":"1year","weight":0.0704},{"period":"ytd","weight":0.0054}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"乐普(北京)医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"108751人(较上一季度增加27.41%)","perCapita":"14518股","listingDate":"2009-10-30","address":"北京市昌平区超前路37号","registeredCapital":"184342万元","survey":" 乐普(北京)医疗器械股份有限公司的主营业务是医疗器械及其配件的技术开发、生产，销售。公司的主要产品是医疗器械、药品、医疗服务、健康管理。公司拥有国家科技部授予的“国家心脏病植介入诊疗器械及装备工程技术研究中心”称号。","listedPrice":29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乐普医疗(300003)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乐普医疗(300003)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乐普医疗,300003,乐普医疗股票,乐普医疗股票老虎,乐普医疗股票老虎国际,乐普医疗行情,乐普医疗股票行情,乐普医疗股价,乐普医疗股市,乐普医疗股票价格,乐普医疗股票交易,乐普医疗股票购买,乐普医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乐普医疗(300003)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乐普医疗(300003)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}